Large-Scale Taxonomic Profiling of Eukaryotic Model Organisms: A Comparison of Orthologous Proteins Encoded by the Human, Fly, Nematode, and Yeast Genomes

  1. Arcady R. Mushegian1,5,
  2. James R. Garey2,
  3. Jason Martin1,4, and
  4. Leo X. Liu3
  1. 1AxyS Pharmaceuticals, Inc., La Jolla, California 92037 USA; 2Department of Biological Sciences, University of South Florida, Tampa, Florida 33620 USA; 3NemaPharm, Inc., Cambridge, Massachusetts 02139 USA

Abstract

Comparisons of DNA and protein sequences between humans and model organisms, including the yeast Saccharomyces cerevisiae, the nematode Caenorhabditis elegans, and the fruit flyDrosophila melanogaster, are a significant source of information about the function of human genes and proteins in both normal and disease states. Important questions regarding cross-species sequence comparison remain unanswered, including (1) the fraction of the metabolic, signaling, and regulatory pathways that is shared by humans and the various model organisms; and (2) the validity of functional inferences based on sequence homology. We addressed these questions by analyzing the available fractions of human, fly, nematode, and yeast genomes for orthologous protein-coding genes, applying strict criteria to distinguish between candidate orthologous and paralogous proteins. Forty-two quartets of proteins could be identified as candidate orthologs. Twenty-four Drosophila protein sequences were more similar to their human orthologs than the corresponding nematode proteins. Analysis of sequence substitutions and evolutionary distances in this data set revealed that most C. elegans genes are evolving more rapidly than Drosophila genes, suggesting that unequal evolutionary rates may contribute to the differences in similarity to human protein sequences. The available fraction ofDrosophila proteins appears to lack representatives of many protein families and domains, reflecting the relative paucity of genomic data from this species.

Footnotes

  • 4 Present address: Genos Biosciences, Inc., La Jolla, California 92037 USA.

  • 5 Corresponding author.

  • E-MAIL arcady{at}axyspharm.com; FAX (619) 452-6653.

    • Received December 15, 1997.
    • Accepted April 21, 1998.
| Table of Contents

Preprint Server